MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.

MLA

Zhu, Jin-Hui, et al. “MiR-139-5p/SLC7A11 Inhibits the Proliferation, Invasion and Metastasis of Pancreatic Carcinoma via PI3K/Akt Signaling Pathway.” Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1866, no. 6, June 2020, p. 165747. EBSCOhost, https://doi.org/10.1016/j.bbadis.2020.165747.

APA

Zhu, J.-H., De Mello, R. A., Yan, Q.-L., Wang, J.-W., Chen, Y., Ye, Q.-H., Wang, Z.-J., Tang, H.-J., & Huang, T. (2020). MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1866(6), 165747. https://doi.org/10.1016/j.bbadis.2020.165747

Chicago

Zhu, Jin-Hui, Ramon Andrade De Mello, Qiu-Liang Yan, Jian-Wei Wang, Yan Chen, Qing-Huang Ye, Zhi-Jiang Wang, Hai-Jun Tang, and Tao Huang. 2020. “MiR-139-5p/SLC7A11 Inhibits the Proliferation, Invasion and Metastasis of Pancreatic Carcinoma via PI3K/Akt Signaling Pathway.” Biochimica et Biophysica Acta. Molecular Basis of Disease 1866 (6): 165747. doi:10.1016/j.bbadis.2020.165747.